HemOnc Today


The following articles appeared in the print edition of HEMONC TODAY.

Table of Contents

Neoadjuvant studies can demonstrate value of new agents in breast cancer

Douglas Yee, MD

All-new Healio.com is designed by you and is ready for its close-up

Memorial Sloan Kettering named best cancer hospital on <em>U.S. News & World Report</em> list

Cover Story

Cancer treatment during pregnancy ‘a constant balancing act’


The changing face of our major meetings: Evolution or revolution?

John Sweetenham, MD, PhD

FDA approvals

FDA approves DNA stool test for colon cancer

In the Journals

MRD-directed therapy improved outcomes in pediatric BCR-ABL1–like ALL

Lower radiation doses, smaller boost volumes minimized intellectual decline in medulloblastoma

False-positive lung cancer screening results did not affect anxiety, quality of life

Trastuzumab associated with durable EFS in HER-2–positive breast cancer

Chemotherapy superior to TKIs in advanced, EGFR wild-type NSCLC

LMWH did not reduce complications in pregnant women with thrombophilia

Papillary thyroid cancer, melanoma demonstrated related risks

ACP: Average-risk women should not undergo routine pelvic exams

Antiviral therapy improved outcomes in HCV-related indolent NHL

Diabetes increased risk for head, neck cancers

High-dose melphalan plus salvage ASCT improved outcomes in relapsed myeloma

Unprovoked VTE, thrombosis at young age increased risk among first-degree relatives

Everolimus failed to improve OS in advanced HCC

HLA-matched donors available for most HSCT candidates

Exemestane had limited negative effect on QOL for postmenopausal women at risk for breast cancer

Long-term survival rates high for pediatric low-grade gliomas

Area poverty rate linked to incidence of certain cancers

Chromosomal instability predicted favorable chemoradiation response in rectal adenocarcinoma

Pemetrexed plus cisplatin active in advanced, recurrent cervical carcinoma

Management of low-risk prostate cancer varied greatly by physician

Regular aspirin use reduced risk for pancreatic cancer

Study identifies link between gut bacteria, post-SCT survival

Lenalidomide plus R-CHOP21 safe, effective in elderly patients with DLBCL

Melanoma risk increased in men who took sildenafil

Radium Ra 223 dichloride safe, effective for prostate cancer bone metastases

Institution Notes

Surgical oncologist joins cancer center

Surgical oncologist named university head and neck department chair

AACR announces board appointments